Breast cancer is the most common cause of cancer death in women.1 PET/CT using Fludeoxyglucose F18 injection (18F FDG) can impact staging and restaging of breast cancer, especially in patients with inflammatory, locally advanced and metastatic breast cancer. Download the white paper to learn about the increasing role PET/CT has in breast cancer in addition to breast cancer treatment guidelines and reimbursement options for certain countries.
FDG PET/CT and breast cancer
|2015-01-02
Did this information help you?
1
IARC. (2013, Dec 12). Latest world cancer statistics Global cancer burden rises to 14.1 million new cases in 2012: Marked increase in breast cancers must be addressed. Press Release Nr 223.